Clean Power Hydrogen plc (CPH2), a UK-based green hydrogen technology company, has recently released an operational and strategic update alongside a proposed fundraising initiative. The Company successfully conducted the Factory Acceptance Test (FAT) for its MFE110 unit, marking the initial customer acceptance of its unique scaled electrolyser technology. CPH2 now aims to move towards full commercialization of its flagship MFE220 unit, with revenue generation targeted for 2025. CPH2 has secured contracts for the sale of four MFE220 units, including deployments to Northern Ireland Water, Fabrum Solutions Limited in New Zealand, and Hidrigin in Ireland. Additionally, the Company has license agreements with various partners to scale up its MFE technology globally. The Board is focused on implementing a business model that emphasizes in-house manufacturing capability, activation of existing licensees, and a capital-efficient approach to drive sustainable growth and maximize shareholder value. Short-term goals include deploying the initial MFE110 unit, completing MFE220 design, and building a commercial team. To support its strategic objectives, CPH2 plans to raise a minimum of £6m through a fundraising of new ordinary shares. The net proceeds will fund working capital requirements, shipping, installation of units, and finalization of the MFE220 design. Shareholders have been informed about the risks associated with the fundraising and its potential impact on the Company's working capital. While the Company has received interest from existing shareholders and investors, the completion of the fundraising on proposed terms is uncertain. CPH2 aims to strengthen its balance sheet and enhance working capital flexibility to advance its green hydrogen technology operations.